(Q36194796)

12 August 2017

1 reference

title

The ubiquitin-proteasome system--micro target for macro intervention? (English)

1 reference

ubiquitin-proteasome system

12 August 2017

main subject

0 references

2

Aaron Ciechanover

1 reference

12 August 2017

3

Lilach O Lerman

1 reference

12 August 2017

4

Amir Lerman

1 reference

12 August 2017

1

Joerg Herrmann

1 reference

12 August 2017

language of work or name

1 reference

1 January 2005

1 reference

International journal of cardiovascular interventions

12 August 2017

published in

1 reference

12 August 2017

volume

7

1 reference

12 August 2017

issue

1

1 reference

12 August 2017

page(s)

5-13

1 reference

New frontiers in interventional cardiology

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

Targeting the molecular target of rapamycin (mTOR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

Microtubules as a target for anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

Isolation of a polypeptide that has lymphocyte-differentiating properties and is probably represented universally in living cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

Structure and functions of the 20S and 26S proteasomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

Themes and variations on ubiquitylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

Activation of ATP-ubiquitin-dependent proteolysis in skeletal muscle in vivo and murine myoblasts in vitro by a proteolysis-inducing factor (PIF)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

Proteome analysis reveals ubiquitin-conjugating enzymes to be a new family of interferon-alpha-regulated genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

Degradation of oxidized proteins by the 20S proteasome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

Modes of regulation of ubiquitin-mediated protein degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

In vivo half-life of a protein is a function of its amino-terminal residue

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

An essential role of N-terminal arginylation in cardiovascular development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

Structural basis for the recognition of hydroxyproline in HIF-1 alpha by pVHL

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

Involvement of valosin-containing protein, an ATPase Co-purified with IkappaBalpha and 26 S proteasome, in ubiquitin-proteasome-mediated degradation of IkappaBalpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

Deadly encounter: ubiquitin meets apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

Oxidation-sensitive transcription factors and molecular mechanisms in the arterial wall.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

SCF(beta)(-TrCP) ubiquitin ligase-mediated processing of NF-kappaB p105 requires phosphorylation of its C-terminus by IkappaB kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

Comparative resistance of the 20S and 26S proteasome to oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

4-hydroxynonenal induces apoptosis, NF-kappaB-activation and formation of 8-isoprostane in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

I kappa B-independent control of NF-kappa B activity by modulatory phosphorylations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

Proteasome inhibitors sensitize human vascular smooth muscle cells to Fas (CD95)-mediated death

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

Proteasome regulation of activation-induced T cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

T-cell immunity in acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

Role of NFkappaB in antigen presentation and development of regulatory T cells elucidated by treatment of dendritic cells with the proteasome inhibitor PSI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

The ubiquitin-proteasome system in cardiovascular diseases-a hypothesis extended

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

Polyubiquitin is a new phenotypic marker of contractile vascular smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

Altered ubiquitin/proteasome expression in anastomotic intimal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

Ubiquitin-proteasome pathway as a new target for the prevention of restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

Involvement of proteasome in endothelin-1 production in cultured vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

A proteasome inhibitor lessens the increased aortic endothelin-1 content in deoxycorticosterone acetate-salt hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

A proteasome inhibitor prevents vascular hypertrophy in deoxycorticosterone acetate-salt hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

Proteasome inhibitors: from research tools to drug candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

The proteasome: a suitable antineoplastic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

The ubiquitin-mediated protein degradation pathway in cancer: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

A phase 2 study of bortezomib in relapsed, refractory myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

Caveolin-1 is required for vascular endothelial growth factor-triggered multiple myeloma cell migration and is targeted by bortezomib

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

Caspase-3-dependent Apoptosis in Vascular Smooth Muscle Cell by Proteasome Inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

The inhibitory role of lactacystin and beta-lactacystin on T-cell activation and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

A proteasome inhibitor effectively prevents mouse heart allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

Chaperone-dependent regulation of endothelial nitric-oxide synthase intracellular trafficking by the co-chaperone/ubiquitin ligase CHIP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

Long-term up-regulation of eNOS and improvement of endothelial function by inhibition of the ubiquitin-proteasome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

Involvement of the proteasome in activation of endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

Increased local vascular endothelial growth factor expression associated with antitumor activity of proteasome inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

Down-regulation of Flt-1 gene expression by the proteasome inhibitor MG262.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

The biology of VEGF and its receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

Downregulation of matrix metalloproteinases and collagens and suppression of cardiac fibrosis by inhibition of the proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

New frontiers in cardiology: drug-eluting stents: Part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

New frontiers in cardiology: drug-eluting stents: Part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

Activation of the Cell Death Program by Nitric Oxide Involves Inhibition of the Proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14628840510011234

Cutting Edge: Regulation of T Cell Activation Threshold by CD28 Costimulation Through Targeting Cbl-b for Ubiquitination

21 January 2018

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1080/14628840510011234

Growth hormone effects on RNA and protein synthesis in liver

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1080/14628840510011234

Endothelin is a potent mitogen for rat vascular smooth muscle cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1080/14628840510011234

Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1080/14628840510011234

Activated nuclear factor-kappaB is present in the coronary vasculature in experimental hypercholesterolemia

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1080/14628840510011234

A proteasome inhibitor reduces concurrent, sequential, and long-term IL-1 beta- and TNF-alpha-induced ECAM expression and adhesion

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1080/14628840510011234

Recent activation of the plaque immune response in coronary lesions underlying acute coronary syndromes.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1080/14628840510011234

Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1 beta

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1080/14628840510011234

Role and function of the 26S proteasome in proliferation and apoptosis.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1080/14628840510011234

Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1080/14628840510011234

IL-1beta-induced monocyte chemoattractant protein-1 gene expression in endothelial cells is blocked by proteasome inhibitors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1080/14628840510011234

Oxidized LDLs alter the activity of the ubiquitin-proteasome pathway: potential role in oxidized LDL-induced apoptosis.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1080/14628840510011234

Proteasome inhibitor prevents experimental arterial thrombosis in renovascular hypertensive rats

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1080/14628840510011234

Inhibition of proteasome function induces programmed cell death in proliferating endothelial cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1080/14628840510011234

Increased ubiquitin immunoreactivity in unstable atherosclerotic plaques associated with acute coronary syndromes

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1080/14628840510011234

Activation-induced ubiquitination of the T cell antigen receptor

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1080/14628840510011234

Effect of selective proteasome inhibitors on TNF-induced activation of primary and transformed endothelial cells.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1080/14628840510011234

Proteasome inhibitors block VCAM-1 and ICAM-1 gene expression in endothelial cells without affecting nuclear translocation of nuclear factor-kappa B

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1080/14628840510011234

The proteasome is involved in angiogenesis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1080/14628840510011234

Antihypertensive effect of a proteasome inhibitor in DOCA-salt hypertensive rats

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1080/14628840510011234

Regulation of ubiquitin-conjugating enzymes by glutathione following oxidative stress

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1080/14628840510011234

Ubiquitin-dependent degradation of certain protein substrates in vitro requires the molecular chaperone Hsc70

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1080/14628840510011234

Induction of ubiquitin-conjugating enzyme by aggregated low density lipoprotein in human macrophages and its implications for atherosclerosis.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1080/14628840510011234

The proteasome pathway is required for cytokine-induced endothelial-leukocyte adhesion molecule expression

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1080/14628840510011234

Identifiers

DOI

10.1080/14628840510011234

1 reference

12 August 2017

1 reference